Table 4.
Periodontal indices and MDA levels at baseline and three months upon therapy completion in groups with PD ≥ 5 mm < 20% and PD ≥ 5 mm ≥ 20%.
| PD ≥ 5 mm < 20% (n = 10) | PD ≥ 5 mm ≥ 20% (n = 20) | |
|---|---|---|
| PI—baseline | 1.24 ± 0.32 | 1.49 ± 0.43 |
| PI—3 mo after therapy | 0.37 ± 0.23 b | 0.54 ± 0.33 b |
| GI—baseline | 1.55 ± 0.54 | 1.93 ± 0.45 |
| GI—3 mo after therapy | 0.48 ± 0.34 b | 0.59 ± 0.44 b |
| PBI—baseline | 1.41 ± 0.74 | 1.67 ± 0.71 |
| PBI—3 mo after therapy | 0.59 ± 0.40 b | 0.78 ± 0.45 b |
| PD (mm)—baseline | 2.58 ± 0.21 | 3.46 ± 0.41 a |
| PD (mm)—3 mo after therapy | 2.21 ± 0.21 b | 2.81 ± 0.40 b |
| CAL (mm)—baseline | 2.22 ± 0.91 | 2.99 ± 1.01 a |
| CAL (mm)—3 mo after therapy | 1.45 ± 0.75 b | 1.98 ± 0.90 b |
| MDA-saliva (pmol/μL)—baseline |
2.62 ± 1.11 | 3.21 ± 1.23 |
| MDA-saliva (pmol/μL)—3 mo after therapy |
2.09 ± 0.88 b | 2.15 ± 1.03 b |
| MDA-plasma (pmol/μL)—baseline |
0.44 ± 0.12 | 0.53 ± 0.12 |
| MDA-plasma (pmol/μL)—3 mo after therapy |
0.42 ± 0.12 | 0.45 ± 0.11 b |
a The difference between subgroups with PD ≥ 5 mm < 20% and PD ≥ 5 mm ≥ 20% was significant at baseline (p < 0.05). b Statistically significant difference compared with the baseline values (p < 0.05).